Terms: = Germ cell tumor AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Treatment
18 results:
1. Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature.
Mulders MCF; Audhoe AS; Van Koetsveld PM; Feelders RA; Hofland LJ; de Herder WW; Kraaij R; Hofland J
Eur J Cancer; 2024 Jan; 197():113472. PubMed ID: 38100919
[TBL] [Abstract] [Full Text] [Related]
2. Association of early surgery and absence of ataxia with full recovery after spinal intramedullary ependymoma resection.
Alhalabi OT; Heene S; Landré V; Neumann JO; Haux D; Zweckberger K; Unterberg AW; Younsi A
J Neurosurg Spine; 2024 Feb; 40(2):185-195. PubMed ID: 37922542
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Differences Between Surveillance and Active treatment After Initial Orchiectomy in Patients With Stage I Mixed germ cell tumors of the Testis: A Propensity Score Matching Analysis.
Du Y; Liu L; Zou B; Chen Z; Chen Q; Deng R; Yang P
J Surg Res; 2024 Feb; 294():26-36. PubMed ID: 37857140
[TBL] [Abstract] [Full Text] [Related]
4. Marital Status Independently Predicts Mortality in Adult Patients with Craniopharyngioma: A SEER-Based Study.
Pham J; Rhee B; Malpass R; Ozcan EE; Shaaya E; Doberstein C; Toms S; Sullivan P
World Neurosurg; 2023 Jul; 175():e367-e379. PubMed ID: 37003530
[TBL] [Abstract] [Full Text] [Related]
5. Recurrent pediatric infratentorial ependymomas: a systematic review and meta-analysis on outcomes and molecular classification.
Montgomery EY; Thirunavu V; Pagadala M; Shlobin NA; Plant-Fox AS; Lam S; DeCuypere M
J Neurosurg Pediatr; 2023 Feb; 31(2):132-142. PubMed ID: 36433871
[TBL] [Abstract] [Full Text] [Related]
6. Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults.
Ferrazzoli V; Shankar A; Cockle JV; Tang C; Al-Khayfawee A; Bomanji J; Fraioli F; Hyare H
Nucl Med Commun; 2023 Jan; 44(1):91-99. PubMed ID: 36378239
[TBL] [Abstract] [Full Text] [Related]
7. Cost-Effectiveness Analysis of Adjuvant Therapy for BRAF-Mutant Resected Stage III Melanoma in Medicare Patients.
Mojtahed SA; Boyer NR; Rao SA; Gajewski TF; Tseng J; Turaga KK
Ann Surg Oncol; 2021 Dec; 28(13):9039-9047. PubMed ID: 34129153
[TBL] [Abstract] [Full Text] [Related]
8. Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications.
Mandel VD; Medri M; Manganoni AM; Pavoni L; De Rosa F; Ribero S; Foca F; Andreis D; Mazzoni L; Magi S; Farnetani F; Palla M; Ulivi P; Stanganelli I
J Dermatolog Treat; 2022 May; 33(3):1368-1375. PubMed ID: 32875931
[TBL] [Abstract] [Full Text] [Related]
9. Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.
Geoerger B; Kang HJ; Yalon-Oren M; Marshall LV; Vezina C; Pappo A; Laetsch TW; Petrilli AS; Ebinger M; Toporski J; Glade-Bender J; Nicholls W; Fox E; DuBois SG; Macy ME; Cohn SL; Pathiraja K; Diede SJ; Ebbinghaus S; Pinto N
Lancet Oncol; 2020 Jan; 21(1):121-133. PubMed ID: 31812554
[TBL] [Abstract] [Full Text] [Related]
10. The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: An analysis of the National Cancer Data Base.
Palm RF; Oliver DE; Yang GQ; Abuodeh Y; Naghavi AO; Johnstone PAS
Cancer; 2019 Feb; 125(4):642-651. PubMed ID: 30644538
[TBL] [Abstract] [Full Text] [Related]
11. Selective ophthalmic artery chemosurgery (SOAC) for retinoblastoma: fluoroscopic time and radiation dose parameters. A baseline study.
Boddu SR; Abramson DH; Marr BP; Francis JH; Gobin YP
J Neurointerv Surg; 2017 Nov; 9(11):1107-1112. PubMed ID: 29030462
[TBL] [Abstract] [Full Text] [Related]
12. Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy.
Shin JY; Diaz AZ
J Neurooncol; 2016 Sep; 129(3):557-565. PubMed ID: 27401155
[TBL] [Abstract] [Full Text] [Related]
13. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I
Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095
[TBL] [Abstract] [Full Text] [Related]
14. Stereotactic interstitial brachytherapy for the treatment of oligodendroglial brain tumors.
El Majdoub F; Neudorfer C; Blau T; Hellmich M; Bührle C; Deckert M; Sturm V; Maarouf M
Strahlenther Onkol; 2015 Dec; 191(12):936-44. PubMed ID: 26307628
[TBL] [Abstract] [Full Text] [Related]
15. IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy.
Minniti G; Scaringi C; Arcella A; Lanzetta G; Di Stefano D; Scarpino S; Bozzao A; Pace A; Villani V; Salvati M; Esposito V; Giangaspero F; Enrici RM
J Neurooncol; 2014 Jun; 118(2):377-383. PubMed ID: 24748470
[TBL] [Abstract] [Full Text] [Related]
16. [Diagnostic and treatment delays do not modify the treatment outcome of patients with multiform glioblastoma].
Noël G; Quetin P; Heymann S; Karamanoukian D; Schott R
Cancer Radiother; 2009 Jan; 13(1):17-23. PubMed ID: 19091619
[TBL] [Abstract] [Full Text] [Related]
17. Effects of the 5-lipoxygenase inhibitors AA-863 and U-60,257 on human glioma cell lines.
Gáti I; Bergström M; Csóka K; Muhr C; Carlsson J
Prostaglandins Leukot Essent Fatty Acids; 1990 Jun; 40(2):117-24. PubMed ID: 2117290
[TBL] [Abstract] [Full Text] [Related]
18. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
Brandt SJ; Peters WP; Atwater SK; Kurtzberg J; Borowitz MJ; Jones RB; Shpall EJ; Bast RC; Gilbert CJ; Oette DH
N Engl J Med; 1988 Apr; 318(14):869-76. PubMed ID: 3281007
[TBL] [Abstract] [Full Text] [Related]
